Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) Shares Outstanding (Diluted Average) (2016 - 2025)

Prestige Consumer Healthcare (PBH) has 16 years of Shares Outstanding (Diluted Average) data on record, last reported at $49.1 million in Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) fell 2.05% year-over-year to $49.1 million; the TTM value through Dec 2025 reached $49.1 million, down 2.05%, while the annual FY2025 figure was $50.1 million, 0.2% changed from the prior year.
  • Shares Outstanding (Diluted Average) reached $49.1 million in Q4 2025 per PBH's latest filing, down from $49.5 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $50.9 million in Q4 2021 and bottomed at $49.1 million in Q4 2025.
  • Average Shares Outstanding (Diluted Average) over 5 years is $50.2 million, with a median of $50.2 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Diluted Average): rose 0.59% in 2021, then decreased 2.05% in 2025.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $50.9 million in 2021, then fell by 1.07% to $50.4 million in 2022, then dropped by 0.53% to $50.1 million in 2023, then fell by 0.08% to $50.1 million in 2024, then decreased by 2.05% to $49.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Diluted Average) were $49.1 million in Q4 2025, $49.5 million in Q3 2025, and $49.8 million in Q2 2025.